MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

MSC-NTF (NurOwn®) exosomes: a novel therapeutic modality in the mouse LPS-induced ARDS model

Abstract Background One of the most severe complications of the current COVID-19 pandemic is acute respiratory distress syndrome (ARDS). ARDS is caused by increased amounts of pro-inflammatory cytokines, leading to lung damage and loss of lung function. There are currently no effective therapies for...

Full description

Bibliographic Details
Main Authors: Haggai Kaspi, Jonathan Semo, Nathalie Abramov, Chen Dekel, Stacy Lindborg, Ralph Kern, Chaim Lebovits, Revital Aricha
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Stem Cell Research & Therapy
Subjects:
Exosomes
Acute respiratory distress syndrome
COVID-19
Mesenchymal stem cells
Lung injury
Online Access:https://doi.org/10.1186/s13287-021-02143-w

Internet

https://doi.org/10.1186/s13287-021-02143-w

Similar Items